Wild Mushrooms and Their Mycelia As Sources of Bioactive Compounds: Antioxidant, Anti-Inflammatory and Cytotoxic Properties
Total Page:16
File Type:pdf, Size:1020Kb
Wild mushrooms and their mycelia as sources of bioactive compounds: antioxidant, anti-inflammatory and cytotoxic properties SOUILEM FEDIA Dissertation submitted to Escola Superior Agrária de Bragança to obtain the Degree of Master in Biotechnological Engineering Supervised by Dr. Anabela R.L. Martins Dr. Isabel C.F.R. Ferreira Dr. Fathia Skhiri Bragança 2016 Dissertation made under the agreement of Double Diploma between the Escola Superior Agrária de Bragança|IPB and the High Institut of Biotechnology of Monastir|ISBM, Tunisia to obtain the Degree of Master in Biotechnological Engineering i ACKNOWLEDGEMENTS First of all, I want to acknowledge my supervisors, Dr. Anabela Martins, Dr. Isabel C.F.R. Ferreira and Dr. Fethia Skhiri, for their generosity and infinite support, great help in laboratory procedures, continuous encouragement and support in the writing of this thesis. My special thanks Dr. Lillian Barros for her practical guidance and encouragement and to Dr. João Barreira for his collaboration in statistical analyses. Many thanks to Dr. Ângela Fernandes and Dr. Ricardo Calhelha for their excellent support in the laboratorial experiments. My profound gratitude to all the people of BioChemCore. I really appreciate all your efforts and I am really happy to be part of your research team. Also, to Mountain Research Centre (CIMO) for all the support. Lastly, I would like also to express my gratitude to all of my friends and my family especially my father Mohamed, my mother Monia, my sister Fida and my brothers Lassaad and Houcem who have helped and given moral support during the happy and sad times; I do not know what I would do without you. Thank you ii TABLE OF CONTENT INDEX OF FIGURES .............................................................................................................. v INDEX OF TABLES .............................................................................................................. vii ABBREVIATIONS LIST ..................................................................................................... viii ABSTRACT ............................................................................................................................. xi RESUMO ................................................................................................................................ xii CHAPTER 1. FRAMEWORK ................................................................................................ 1 CHAPTER 2. INTRODUCTION .......................................................................................... 2 1. Studied mushroom species ............................................................................................ 2 1.1 Pleurotus eryngii (DC.) Quél. .................................................................................. 2 1.2 Suillus bellinii (Inzenga) Watling ............................................................................ 3 2. Bioactive compound in wild mushrooms .................................................................... 4 2.1 Phenolic acids .......................................................................................................... 4 2.2 Ergosterol ............................................................................................................... 10 3. Bioactivity of wild mushroom extracts ...................................................................... 11 3.1 Antioxidant activity ............................................................................................... 12 3.2 Anti-inflammatory activity .................................................................................... 15 3.3 Cytotoxic activity ................................................................................................... 16 4. Production of mushroom mycelia by in vitro culture ............................................... 18 4.1 In vitro culture applied to mushrooms ................................................................... 18 4.2 Case-studies with wild mushrooms ....................................................................... 19 5. Objectives ..................................................................................................................... 21 CHAPTER 3. MATERIALS AND METHODS .................................................................. 22 1. Wild samples and in vitro production of mycelia ..................................................... 22 2. Standards and reagents .............................................................................................. 22 3. Preparation of the extracts ......................................................................................... 23 4. Chemical characterization of the extracts ................................................................ 23 iii 4.1 Analysis of phenolic acids ..................................................................................... 23 4.2 Analysis of ergosterol ............................................................................................ 24 5. Evaluation of bioactive properties ............................................................................. 25 5.1 Antioxidant activity ............................................................................................... 25 5.1.1 DPPH radical scavenging activity ................................................................... 25 5.1.2 Reducing power ............................................................................................... 26 5.1.3 Inhibition of 훽-carotene bleaching .................................................................. 27 5.1.4 Thiobarbituric acid reactive substances (TBARS) assay ................................ 28 5.2 Anti-inflammatory activity .................................................................................... 28 5.2.1 Cells treatment ................................................................................................. 29 5.2.2 Nitric oxide determination .............................................................................. 29 5.3 Cytotoxic activity ................................................................................................... 30 5.3.1 In human tumor cell lines ................................................................................ 30 5.3.2 In non-tumor cells ........................................................................................... 31 6. Statistical ...................................................................................................................... 32 CHAPTER 4. RESULTS AND DISCUSSION .................................................................... 33 1. Mycelia growth ............................................................................................................ 33 2. Chemical characterization of the extracts ................................................................ 35 3. Antioxidant activity ..................................................................................................... 38 4. Anti-inflammatory activity ......................................................................................... 40 5. Cytotoxic activity ......................................................................................................... 41 CHAPTER 5. CONCLUDING REMARKS AND FUTURE PERSPECTIVES ............. 44 REFERENCES ....................................................................................................................... 46 iv INDEX OF FIGURES Figure 1. Fruiting body of Pleurotus eryngii (DC.) Quél. ....................................................... 2 Figure 2. Fruiting body of Suillus bellinii (Inzenga) Watling .................................................. 4 Figure 3. Chemical structures of benzoic and cinnamic acid derivatives usually found in mushrooms (Heleno et al., 2014). .............................................................................................. 6 Figure 4. General representation of the phenolic acids biosynthesis derived from the shikimic acid pathway. (Heleno et al., 2014). The numbers find the correspondence in the entries of Table 2. ....................................................................................................................................... 7 Figure 5. Steroid nucleus. ........................................................................................................ 10 Figure 6. Chemical structure of ergosterol. ............................................................................. 10 Figure 7. Major causes for over production of free radical (oxidative stress), possible cellular targets and conditions that were associated to oxidative stress (Ferreira et al., 2009). ............ 12 Figure 8. Natural antioxidants separated in classes. Green words represent exogenous antioxidants, while yellow ones represent endogenous antioxidants (Carocho & Ferreira, 2013a). ...................................................................................................................................... 13 Figure 9. Overview of the main reactions involving reactive Oxygen species (ROS) / reactive Nitrogen species (RNS), and major endogenous enzymatic and non-enzymatic antioxidant defenses in the cell. The most representative endogenous sources (traced rectangles) of ROS/RNS are presented and include: Mitochondrial ETS (Electron transport system), NADPH oxidases, Xanthine oxidase for ROS and NO synthases for RNS. The main antioxidant defenses are